Blog
News September 9, 2021
CaaMTech Raises $22M in Series A Funding
– CaaMTech is a psychedelic drug discovery company. – The company raised $22M in Series A funding. – The round was led by Noetic Fund. – The new investment will be used to support the company’s cross-disciplinary science program, expand its leadership team, and advance its foremost drug development candidates into human trials.
News September 8, 2021
Marpipe Raises $8M Series A to Build the Operating System for Creative Testing
News September 8, 2021
SingleStore Fuels Triple-Digit Cloud Growth with $80M in New Funding
News September 8, 2021
HoneyBee raises millions to make financial wellness a workplace benefit
News September 7, 2021
Portcast gets $3.2M to create more transparent and sustainable supply chains
News September 7, 2021
Tritium Announces AUD$40 million Private Placement Financing by Cigna Investments, Inc.
News September 7, 2021